Pfizer, Merck KGaA’s Bavencio breaks into new bladder cancer field with latest FDA nod!

Pfizer, Merck KGaA’s Bavencio breaks into new bladder cancer field with latest FDA nod!

Bavencio is the only drug in its class approved in the first-line maintenance setting for bladder cancer. (Pfizer)

PharmahubNG

Welcome to Pharmahub!